0001209191-20-061502.txt : 20201203 0001209191-20-061502.hdr.sgml : 20201203 20201203163419 ACCESSION NUMBER: 0001209191-20-061502 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201203 FILED AS OF DATE: 20201203 DATE AS OF CHANGE: 20201203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shepard Jay CENTRAL INDEX KEY: 0001587788 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34620 FILM NUMBER: 201367338 MAIL ADDRESS: STREET 1: 15977 GRANDVIEW AVENUE CITY: MONTE SERENO STATE: CA ZIP: 95030 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IRONWOOD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001446847 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043404176 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 SUMMER STREET, SUITE 2300 CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 617-621-7722 MAIL ADDRESS: STREET 1: 100 SUMMER STREET, SUITE 2300 CITY: BOSTON STATE: MA ZIP: 02110 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-03 0 0001446847 IRONWOOD PHARMACEUTICALS INC IRWD 0001587788 Shepard Jay C/O IRONWOOD PHARMACEUTICALS, INC. 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 1 0 0 0 Class A Common Stock 2020-12-03 4 A 0 24727 0.00 A 24727 D Class A Common Stock 2020-12-03 4 A 0 10830 0.00 A 35557 D The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in three equal installments on the first three anniversaries of the date of grant. The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year. /s/ Conor Kilroy, Attorney-in-Fact 2020-12-03